cas: 1454846-35-5 — see every product listed under this CAS number, including other names
Lorlatinib (CAS 1454846-35-5) is a chemical reagent available from Chemat. Available pack sizes: 0,05g, 0,1g, 0,25g, 0,5g, 1g. Offered by: Biosynth.
| brand | Biosynth |
|---|---|
| catalog number | FP104236-0,05g |
| cas | 1454846-35-5 |
| size | 0,05g |
Ask us about this product — we're happy to help.
| brand | size | price | |
|---|---|---|---|
| Biosynth | 0,05g | price on request | |
| Biosynth | 0,1g | price on request | |
| Biosynth | 0,25g | price on request | |
| Biosynth | 0,5g | price on request | |
| Biosynth | 1g | price on request |
| category | Life Sciences |
|---|---|
| sub-category 1 | Ligands |
| sub-category 2 | Enzyme Modulators |
| purity | No data |
| delivery time | 1-2 weeks |
Lorlatinib is a cyclic ether that is 16,17-dihydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-15(10H)-one substituted by methyl groups at positions 2 and 10R, and by cyano, amino and fluoro groups at positions 3, 7 and 12 respectively. It is a small molecule inhibitor of ALK and ROS1 kinase developed by Pfizer for the treatment of ALK-positive non-small cell lung cancer. It has a role as an antineoplastic agent and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a nitrile, a member of benzamides, a member of pyrazoles, an aromatic ether, a cyclic ether, an organic heterotetracyclic compound, an aminopyridine, an azamacrocycle and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C21H19FN6O2 |
|---|---|
| Molecular weight | 406.4 g/mol |
| IUPAC name | (16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile |
| InChIKey | IIXWYSCJSQVBQM-LLVKDONJSA-N |
| SMILES | C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C |
Computed by PubChem (NCBI)